Market Alert : Will the RBA’s Next Rate Move Keep Australian Investors on Edge?

Mayank Bansal
Mayank Bansal, CFA
Mayank Bansal is a CFA Charterholder and heads the Equity Research team at Kapitales Research, with over 5 years of experience analysing global equity markets. He leads fundamental, data-driven research combining rigorous financial analysis with macro trends.

Orica FY2026 Results: Can Record Earnings Outrun One-Off Costs?

Orica FY2026 Results: Can Record Earnings Outrun One-Off Costs? Source: Kapitales Research

Orica Limited (ASX: ORI) announced its half-year FY2026 results on 7 May 2026, reporting stronger underlying earnings despite slightly softer revenue and substantial significant items. Sales revenue for the six months ended 31 March 2026 declined 1% to AU$3.88 billion, while EBIT advanced 5% to AU$512.0 million. Underlying NPAT attributable to shareholders increased 8% to AU$283.1 million, highlighting improving earnings quality across the mining-services portfolio.Highlights:

  • Underlying profit climbed 8%, but significant costs almost erased statutory earnings.
  • Digital and specialty chemicals delivered double-digit EBIT growth, strengthening portfolio diversification.
  • A higher dividend signals confidence, while cash generation faces near-term pressure.

Earnings Strength Emerges Beneath Flat RevenueOrica’s headline revenue movement understated the improvement in profitability. EBITDA rose 4% to AU$761.4 million and EBIT increased 5% to AU$512.0 million, despite sales easing to AU$3.88 billion. Underlying NPAT reached AU$283.1 million, compared with AU$263.0 million a year earlier.

Digital Solutions was a standout, with EBIT rising 25% to AU$51.1 million, supported by greater adoption of digital products, recurring revenue and margin expansion. Specialty Mining Chemicals EBIT increased 20% to AU$56.5 million, while Blasting Solutions remained broadly stable at AU$434.9 million.

However, AU$283.7 million of significant items after tax reduced statutory earnings attributable to shareholders to a AU$0.6 million loss. These items primarily reflected litigation costs and outcomes, alongside supply disruption and restructuring expenses.Shareholder Returns Rise as Cash Flow SoftensThe Board declared an unfranked interim dividend of 28.5 cents per share, up 14% year-on-year and representing a 47% payout ratio. The dividend was scheduled for payment on 3 July 2026.

Operating cash flow nevertheless declined to AU$230.6 million from AU$244.9 million. Higher working capital, foreign exchange movements, US litigation expenditure and additional sourcing costs weighed on cash conversion.Strategic Growth Adds Another CatalystOrica is also positioning for longer-term expansion through its planned acquisition of Nelson Brothers’ North American explosives business and the acquired Danafloat product range. Meanwhile, an organisation-wide efficiency program targets at least AU$100 million in enduring cost reductions, with most benefits expected from 2027 onward.Outlook: Can Momentum Extend Through FY2026?Management expects full-year underlying EBIT to increase across every segment and region, assuming no new unforeseen disruptions. Existing-business capital expenditure should remain broadly consistent with FY2025, although operating cash flow is forecast below last year.

The key question is whether stronger digital adoption, specialty chemicals growth, acquisitions and cost savings can outweigh geopolitical, currency and supply-chain pressures. With underlying earnings advancing and portfolio diversification improving, Orica enters the second half with solid operational momentum, but cash conversion and execution remain important measures of whether that momentum translates into sustainable shareholder value.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise. 

 

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au